These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26518921)

  • 21. Therapeutic plasma exchange for desensitization prior to transplantation in ABO-incompatible renal allografts.
    Sivakumaran P; Vo AA; Villicana R; Peng A; Jordan SC; Pepkowitz SH; Klapper EB
    J Clin Apher; 2009; 24(4):155-60. PubMed ID: 19658162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal dose of rituximab in ABO-incompatible kidney transplantation in patients with low anti-A/B antibody titers: A single-center retrospective cohort study.
    Okada M; Narumi S; Hasegawa Y; Futamura K; Hiramitsu T; Ichimori T; Goto N; Kobayashi T; Uchida K; Takeda A; Watarai Y
    Clin Transplant; 2023 Feb; 37(2):e14915. PubMed ID: 36634703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: Advantages and disadvantages of rituximab pretreatment.
    Okada M; Watarai Y; Iwasaki K; Murotani K; Futamura K; Yamamoto T; Hiramitsu T; Tsujita M; Goto N; Narumi S; Takeda A; Morozumi K; Uchida K; Kobayashi T
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28792635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABO-Incompatible Kidney Transplantation: Low Rates of Infectious Complications and Excellent Patient Survival.
    Shah Y; Almeshari K; Broering D; Aleid H; Brockmann J; Alhumaidan H; Hammad E; Elgamal H; Alahmadi I; Hussein M; Ibrahim I; Ali T
    Transplant Proc; 2019 Mar; 51(2):512-516. PubMed ID: 30879579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term Follow-up of ABO-Incompatible Kidney Transplantation in Freiburg, Germany: A Single-Center Outcome Report.
    Langhorst C; Ganner A; Schneider J; Prager EP; Walz G; Pisarski P; Jänigen B; Zschiedrich S
    Transplant Proc; 2021 Apr; 53(3):848-855. PubMed ID: 33041078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up.
    Genberg H; Kumlien G; Wennberg L; Berg U; Tydén G
    Transplantation; 2008 Jun; 85(12):1745-54. PubMed ID: 18580466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation.
    Takahashi K; Saito K; Takahara S; Fuchinoue S; Yagisawa T; Aikawa A; Watarai Y; Yoshimura N; Tanabe K; Morozumi K; Shimazu M;
    Clin Exp Nephrol; 2017 Aug; 21(4):705-713. PubMed ID: 27534951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ABO-incompatible transplantation without conventional induction immunosuppression (IL-2RB or depleting agents).
    Hafeeq B; Aziz F; Narayanan S; Aboobacker IN; Gopinathan JC; Narayanan R; Binu JJ; Uvais NA
    Saudi J Kidney Dis Transpl; 2020; 31(3):572-581. PubMed ID: 32655043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Desensitization with antigen-specific immunoadsorption interferes with complement in ABO-incompatible kidney transplantation.
    Biglarnia AR; Nilsson B; Nilsson Ekdahl K; Tufveson G; Nilsson T; Larsson E; Wadström J
    Transplantation; 2012 Jan; 93(1):87-92. PubMed ID: 22113493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histological and Extended Clinical Outcomes After ABO-Incompatible Renal Transplantation Without Splenectomy or Rituximab.
    Chow KV; Flint SM; Shen A; Landgren A; Finlay M; Murugasu A; Masterson R; Hughes P; Cohney SJ
    Transplantation; 2017 Jun; 101(6):1433-1440. PubMed ID: 27495772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desensitization with plasmapheresis and anti-Cd20 for ABO incompatible kidney transplantation from living donor: experience of a single center in Italy.
    Silvestre C; Furian L; Marson P; Tison T; Valente M; Marchini F; Rossi B; Bonfante L; Valerio F; Cozzi E; Rigotti P
    Transplant Proc; 2014 Sep; 46(7):2209-13. PubMed ID: 25242753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era.
    Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Kang SH; Jung BH; Yoon YI; Kim N
    J Hepatol; 2014 Sep; 61(3):575-82. PubMed ID: 24801413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of ABO incompatible kidney transplantation on living donor transplantation.
    Yu JH; Chung BH; Yang CW;
    PLoS One; 2017; 12(3):e0173878. PubMed ID: 28323892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [ABO INCOMPATIBLE KIDNEY TRANSPLANTATION].
    Eisner S; Orlin J; Nesher E; Mazhybovsky V; Gurevich M; Michowiz R; Rahamimov R; Mor E
    Harefuah; 2017 Apr; 156(4):237-241. PubMed ID: 28551928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes and complications following ABO-incompatible kidney transplantation performed after desensitization by semi-selective immunoadsorption - a retrospective study.
    Speer C; Kälble F; Nusshag C; Pego da Silva L; Schaier M; Becker LE; Klein K; Sommerer C; Beimler J; Leo A; Waldherr R; Mehrabi A; Süsal C; Zeier M; Morath C
    Transpl Int; 2019 Dec; 32(12):1286-1296. PubMed ID: 31322786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation.
    Sugiyama K; Hyodo Y; Aikawa A
    Int J Urol; 2015 Oct; 22(10):931-6. PubMed ID: 26108258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplant outcomes of 100 cases of living-donor ABO-incompatible kidney transplantation.
    Yin S; Tan Q; Yang Y; Zhang F; Song T; Fan Y; Huang Z; Lin T; Wang X
    Chin Med J (Engl); 2022 Oct; 135(19):2303-2310. PubMed ID: 36103981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABO incompatible living donor kidney transplantation in Korea: highly uniform protocols and good medium-term outcome.
    Kong JM; Ahn J; Park JB; Chung BH; Yang J; Kim JK; Huh KH; Kim JM
    Clin Transplant; 2013; 27(6):875-81. PubMed ID: 24118271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.
    Kauke T; Klimaschewski S; Schoenermarck U; Fischereder M; Dick A; Guba M; Stangl M; Werner J; Meiser B; Habicht A
    PLoS One; 2016; 11(1):e0146075. PubMed ID: 26730981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of Anti-ABO Immunoglobulin G Subclass and C1q Antibody in ABO-incompatible Kidney Transplantation.
    Lee KH; Won DI; Yook JM; Kim KY; Park SM; Park JH; Lee ES; Lim JH; Jung HY; Choi JY; Park SH; Kim CD; Kim YL; Kim HK; Huh S; Cho JH
    Transplant Proc; 2018 May; 50(4):1063-1067. PubMed ID: 29731066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.